Holland & Knight Health Dose: March 19, 2025

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

• Looking Ahead: First Break for Congress
• Hearings This Week: None Scheduled
• Week in Review: Senate Passes CR to Avoid Shutdown
• Dr. Mehmet Oz Appeared Before Senate Finance Committee for Confirmation Hearing
• Executive Order Updates
• Additional EOs Issued by Previous Administration Rescinded
• Make America Healthy Again (MAHA) Commission Holds First Meeting
• Personnel Updates
• Reconciliation
• HALT Fentanyl Act (S. 331) Passes Senate
• Congressional Doctors Caucus Added to Caucus List, Criticizes Physician Fee Schedule Cuts
• CDC Workgroup Announced by HELP Committee Chair Cassidy
• Tariffs on Mexico, Canada and China Update
• Deadline to Register for CMS Medicare Drug Price Negotiation Public Events Extended
• CMMI Models Canceled
• HHS Eliminates 6 Regional Offices for Legal Staff
• WHO Designates Collaborating Centre on AI for Health Governance

Read the full Health Dose »